Cochrane Abstracts
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity Edited (no change to conclusions)
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Down‐titration and Discontinuation Strategies of Tumour Necrosis Factor–blocking Agents for Rheumatoid Arthritis in Patients With Low Disease Activity Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437202/all/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity_Edited__no_change_to_conclusions_. Accessed 28 September 2020.
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437202/all/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity_Edited__no_change_to_conclusions_. Accessed September 28, 2020.
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity Edited (no change to conclusions). In Cochrane Abstracts Retrieved September 28, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/437202/all/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity_Edited__no_change_to_conclusions_
Down‐titration and Discontinuation Strategies of Tumour Necrosis Factor–blocking Agents for Rheumatoid Arthritis in Patients With Low Disease Activity Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2020 September 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437202/all/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity Edited (no change to conclusions)
ID - 437202
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437202/all/Down‐titration_and_discontinuation_strategies_of_tumour_necrosis_factor–blocking_agents_for_rheumatoid_arthritis_in_patients_with_low_disease_activity_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
